Picture BIO Deutschland German Biotech Days 2019 Würzburg 600x60px
Document › Details

Orbach, Meir [CalcalisTech]. (1/1/18). "News: Pontifax Raises a $240 Million Fifth Fund. Life Sciences-focused Venture Capital Firm Pontifax Is Expected to Invest Most of the New Fund in the Pharmaceutical Industry".

Region Region Israel
Organisations Organisation Pontifax (Fund V)
  Group Pontifax Ltd.
  Organisation 2 Kite Pharma Inc. (Nasdaq: KITE)
  Group Gilead Sciences (Group)
Products Product Pontifax (Fund V)
Index terms Index term Pontifax–SEVERAL: investment, 201710–201801 closing $240m of new fifth fund
  Index term 2 Kite Pharma–Pontifax: investment, –201708 Pontifax as one of first investors invested $3.8m yielding return of $130m w sale of Kite to Gilead
Persons Person Arkin, Mori (Arkin Holdings)
  Person 2 Nussbaum, Ran (Pontifax 200712 Managing Partner also CEO of Biomedix Incubator)

Record changed: 2018-01-08


Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

More documents for Pontifax Ltd.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px

» top